Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203846

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 203846 describes METHAMPHETAMINE HYDROCHLORIDE, which is a drug marketed by Able, Hikma, Mayne Pharma Inc, Rexar, and Teva, and is included in five NDAs. It is available from two suppliers. Additional details are available on the METHAMPHETAMINE HYDROCHLORIDE profile page.

The generic ingredient in METHAMPHETAMINE HYDROCHLORIDE is methamphetamine hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
Summary for 203846
Ingredient:methamphetamine hydrochloride
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 203846
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHAMPHETAMINE HYDROCHLORIDE methamphetamine hydrochloride TABLET;ORAL 203846 ANDA West-Ward Pharmaceuticals Corp. 0054-0389 0054-0389-25 100 TABLET in 1 BOTTLE (0054-0389-25)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Nov 17, 2015TE:AARLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.